{"id":"https://openalex.org/W4245532406","doi":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78","title":"Abstract 78: The Association of Home Warfarin Therapy with Acute Treatment Patterns and Bleeding Risk in Patients Presenting with ST-Elevation Myocardial Infarction: Results from the NCDR \u00ae","display_name":"Abstract 78: The Association of Home Warfarin Therapy with Acute Treatment Patterns and Bleeding Risk in Patients Presenting with ST-Elevation Myocardial Infarction: Results from the NCDR \u00ae","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W4245532406","doi":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78"},"language":"en","primary_location":{"id":"doi:10.1161/circoutcomes.6.suppl_1.a78","doi":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78","pdf_url":null,"source":{"id":"https://openalex.org/S52278559","display_name":"Circulation Cardiovascular Quality and Outcomes","issn_l":"1941-7705","issn":["1941-7705","1941-7713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation: Cardiovascular Quality and Outcomes","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016149585","display_name":"Wassef Karrowni","orcid":"https://orcid.org/0000-0002-5622-130X","observed_orcids":["https://orcid.org/0000-0002-5622-130X"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wassef Karrowni","raw_affiliation_strings":["Univ of Iowa Carver College of Medicine, Iowa City, IA","Wassef Karrowni"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Iowa Carver College of Medicine, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]},{"raw_affiliation_string":"Wassef Karrowni","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033163802","display_name":"Tracy Y Wang","orcid":"https://orcid.org/0000-0002-3318-3777","observed_orcids":["https://orcid.org/0000-0002-3318-3777"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracy Y Wang","raw_affiliation_strings":["Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","Tracy Y Wang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Tracy Y Wang","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071176966","display_name":"Anita Y. Chen","orcid":"https://orcid.org/0000-0003-2755-7637","observed_orcids":["https://orcid.org/0000-0003-2755-7637"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita Y Chen","raw_affiliation_strings":["Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","Anita Y Chen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Anita Y Chen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043643766","display_name":"Laine Elliott Thomas","orcid":"https://orcid.org/0000-0002-5340-8742","observed_orcids":["https://orcid.org/0000-0002-5340-8742"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laine Thomas","raw_affiliation_strings":["Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","Laine Thomas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Rsch Inst, Duke Univ Med Cntr, Durham, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Laine Thomas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109112529","display_name":"Jorge Felix Saucedo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge F Saucedo","raw_affiliation_strings":["Univ of Oklahoma Health Sciences Cntr, Oklahoma City, OK","Jorge F Saucedo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Oklahoma Health Sciences Cntr, Oklahoma City, OK","institution_ids":["https://openalex.org/I49332381"]},{"raw_affiliation_string":"Jorge F Saucedo","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023814427","display_name":"Ramzi N El Accaoui","orcid":"https://orcid.org/0000-0002-5515-5427","observed_orcids":["https://orcid.org/0000-0002-5515-5427"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramzi N El Accaoui","raw_affiliation_strings":["Univ of Iowa Carver College of Medicine, Iowa City, IA","Ramzi N El Accaoui"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Iowa Carver College of Medicine, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]},{"raw_affiliation_string":"Ramzi N El Accaoui","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9018999934196472,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9018999934196472,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.09220000356435776,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/st-elevation-myocardial-infarction","display_name":"ST-elevation myocardial infarction","score":0.9900000095367432},{"id":"https://openalex.org/keywords/primary-percutaneous-coronary-intervention","display_name":"primary percutaneous coronary intervention","score":0.9359999895095825},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/glycoprotein-iib-iiia-inhibitors","display_name":"glycoprotein IIb/IIIa inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/door-to-balloon-time","display_name":"door-to-balloon time","score":0.9100000262260437},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.8149999976158142},{"id":"https://openalex.org/keywords/bivalirudin","display_name":"bivalirudin","score":0.949999988079071},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":0.9309999942779541},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.9639999866485596},{"id":"https://openalex.org/keywords/international-normalized-ratio","display_name":"international normalized ratio","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9514727592468262},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.872321605682373},{"id":"https://openalex.org/C2777565915","wikidata":"https://www.wikidata.org/wiki/Q4919218","display_name":"Bivalirudin","level":4,"score":0.8624707460403442},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.7696552276611328},{"id":"https://openalex.org/C2777028646","wikidata":"https://www.wikidata.org/wiki/Q416232","display_name":"Prasugrel","level":4,"score":0.7090358734130859},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.6290249228477478},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6205675005912781},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.5763720273971558},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5589138865470886},{"id":"https://openalex.org/C45393284","wikidata":"https://www.wikidata.org/wiki/Q191012","display_name":"Conventional PCI","level":3,"score":0.5459451079368591},{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.5305816531181335},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3864251375198364},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.3670918941497803},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.33461111783981323},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32179397344589233}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circoutcomes.6.suppl_1.a78","doi":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circoutcomes.6.suppl_1.a78","pdf_url":null,"source":{"id":"https://openalex.org/S52278559","display_name":"Circulation Cardiovascular Quality and Outcomes","issn_l":"1941-7705","issn":["1941-7705","1941-7713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation: Cardiovascular Quality and Outcomes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7095376967","https://openalex.org/W2120139446","https://openalex.org/W2939987692","https://openalex.org/W2892726846","https://openalex.org/W2040934048","https://openalex.org/W2021870531","https://openalex.org/W86729273","https://openalex.org/W1517426702","https://openalex.org/W2060317823","https://openalex.org/W4404357042"],"abstract_inverted_index":{"Introduction:":[0],"Bleeding":[1],"complications":[2],"during":[3],"acute":[4,51],"coronary":[5,64],"syndrome":[6],"care":[7],"are":[8,319],"independent":[9],"predictors":[10],"of":[11,34,43,99,116,138,163,183,269,300,309],"adverse":[12],"outcomes.":[13],"Patients":[14],"presenting":[15],"with":[16,61,74,174,206,265,286,294,313],"ST-elevation":[17],"myocardial":[18],"infarction":[19],"(STEMI)":[20],"receiving":[21],"warfarin":[22,127,134,156,211,224,249,261,290],"therapy":[23,135,262,291],"at":[24,77,128,179,225],"home":[25,105,133,155,210,226,248,289],"represent":[26],"a":[27],"management":[28],"challenge":[29],"especially":[30],"in":[31,37,57,245,297,326],"the":[32,41,50,93,112,298,305],"absence":[33],"specific":[35],"recommendations":[36],"current":[38],"guidelines.":[39],"Given":[40],"paucity":[42],"data,":[44],"this":[45,327],"study":[46],"aims":[47],"to":[48,192,200,221,242,321],"describe":[49],"treatment":[52,310],"patterns":[53],"and":[54,108,123,136,159,170,195,203,234,254],"bleeding":[55,141,272,303,315,323],"risk":[56,137,268,299],"STEMI":[58,71,152,283],"patients":[59,72,89,101,121,153,184,222,246,284],"treated":[60,73,285],"primary":[62,75,287],"percutaneous":[63],"intervention":[65],"(PCI).":[66],"Methods:":[67],"We":[68],"examined":[69],"120,270":[70],"PCI":[76],"586":[78],"ACTION":[79],"Registry":[80],"\u00ae":[81],"-GWTG":[82],"TM":[83],"hospitals":[84],"between":[85,120,132],"2007-":[86],"2012,":[87],"excluding":[88],"who":[90],"died":[91],"within":[92,111],"first":[94,113],"24":[95,114],"hours.":[96],"A":[97],"total":[98],"3,101":[100],"(2.6%)":[102],"were":[103,118,157,189,216,239],"on":[104,154,209,247],"warfarin.":[106],"Antiplatelet":[107],"anticoagulant":[109],"regimens":[110,311],"hours":[115],"admission":[117],"compared":[119,173,205],"taking":[122,126,177,223],"those":[124,175,207],"not":[125,176,208],"home.":[129],"The":[130],"association":[131],"in-hospital":[139,270,301],"major":[140,271,302],"was":[142,263],"analyzed":[143],"using":[144],"multivariable":[145],"logistic":[146],"generalized":[147],"estimating":[148],"equations":[149],"method.":[150],"Results:":[151],"older":[158],"had":[160,185],"higher":[161,267,314],"prevalence":[162],"co-morbid":[164],"conditions":[165],"such":[166],"as":[167],"hypertension,":[168],"diabetes,":[169],"renal":[171],"disease":[172],"warfarin;":[178],"presentation":[180],"only":[181],"35.6%":[182],"INR":[186],"\u22652.0.":[187],"They":[188],"less":[190,218,240,306],"likely":[191,199,241],"receive":[193,201],"prasugrel":[194],"heparin,":[196],"but":[197],"more":[198],"clopidogrel":[202],"bivalirudin":[204],"(Table).":[212,227],"Glycoprotein":[213],"IIbIIIa":[214],"inhibitors":[215],"also":[217],"commonly":[219],"administered":[220],"Door-to-balloon":[228],"\u226490":[229],"minutes":[230,236],"for":[231,237],"direct":[232],"arrivals":[233],"\u2264120":[235],"transfers":[238],"be":[243],"achieved":[244],"(83.5%":[250],"vs.":[251,256],"88.5%,":[252],"p<0.0001":[253],"47.5%":[255],"57.1%,":[257],"p<0.0001,":[258],"respectively).":[259],"Home":[260],"associated":[264,293,312],"significantly":[266],"(17.0%":[273],"vs":[274],"10.1%;":[275],"adjusted":[276],"odds":[277],"ratio":[278],"1.26":[279],"[1.13-1.40]).":[280],"Conclusions:":[281],"In":[282],"PCI,":[288],"is":[292],"significant":[295],"increase":[296],"despite":[304],"frequent":[307],"use":[308],"risk.":[316],"Future":[317],"studies":[318],"needed":[320],"identify":[322],"avoidance":[324],"strategies":[325],"high-risk":[328],"population.":[329]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-05-12T00:00:00"}